The most common interventions in structural heart diseases for various age groups are percutaneous
occlusions of septal defects. We present the case of a woman with patent foramen ovale
(PFO) periodically causing a right-to-left shunt, after an incident of stroke, with migraine
attacks, treated by percutaneous closure of PFO with use of a novel occluder device - an
Occlutech Figulla®. The procedure was performed under X-ray and transesophageal
echocardiographic monitoring. The novel Occlutech device described above features easy manipulation,
good safety and some constructional innovations that enable the time of antiplatelet
prophylaxis to be shortened, thus potentially minimizing procedure related risk
